United Therapeutics Corp. (UTHR)
513.04
-0.08
(-0.02%)
USD |
NASDAQ |
Aug 24, 16:00
513.04
0.00 (0.00%)
After-Hours: 20:00
United Therapeutics Price to Book Value : 3.421 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 3.422 |
| August 20, 2026 | 3.474 |
| August 19, 2026 | 3.528 |
| August 18, 2026 | 3.456 |
| August 17, 2026 | 3.390 |
| August 14, 2026 | 3.332 |
| August 13, 2026 | 3.342 |
| August 12, 2026 | 3.412 |
| August 11, 2026 | 3.437 |
| August 10, 2026 | 3.532 |
| August 07, 2026 | 3.593 |
| August 06, 2026 | 3.554 |
| August 05, 2026 | 3.461 |
| August 04, 2026 | 3.458 |
| August 03, 2026 | 3.443 |
| July 31, 2026 | 3.452 |
| July 30, 2026 | 3.506 |
| July 29, 2026 | 3.499 |
| July 28, 2026 | 3.492 |
| July 27, 2026 | 3.520 |
| July 24, 2026 | 3.524 |
| July 23, 2026 | 3.531 |
| July 22, 2026 | 3.514 |
| July 21, 2026 | 3.573 |
| July 20, 2026 | 3.530 |
| Date | Value |
|---|---|
| July 17, 2026 | 3.572 |
| July 16, 2026 | 3.528 |
| July 15, 2026 | 3.546 |
| July 14, 2026 | 3.512 |
| July 13, 2026 | 3.571 |
| July 10, 2026 | 3.648 |
| July 09, 2026 | 3.684 |
| July 08, 2026 | 3.696 |
| July 07, 2026 | 3.759 |
| July 06, 2026 | 3.649 |
| July 02, 2026 | 3.707 |
| July 01, 2026 | 3.648 |
| June 30, 2026 | 3.613 |
| June 29, 2026 | 3.893 |
| June 26, 2026 | 3.877 |
| June 25, 2026 | 3.882 |
| June 24, 2026 | 3.928 |
| June 23, 2026 | 3.889 |
| June 22, 2026 | 3.846 |
| June 18, 2026 | 3.833 |
| June 17, 2026 | 3.940 |
| June 16, 2026 | 3.917 |
| June 15, 2026 | 3.926 |
| June 12, 2026 | 3.900 |
| June 11, 2026 | 3.896 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Liquidia Corp. | 32.09 |
| Insmed, Inc. | 35.74 |
| MannKind Corp. | -- |
| Vertex Pharmaceuticals, Inc. | 6.854 |
| BioMarin Pharmaceutical, Inc. | 1.991 |
Price to Book Value Related Metrics
| PE Ratio | 18.35 |
| PS Ratio | 7.628 |
| PEG Ratio | 2.003 |
| Price to Free Cash Flow | 22.19 |
| Price | 513.04 |
| Earnings Yield | 5.45% |
| Market Cap | 21.89B |
| PEGY Ratio | 2.003 |
| Operating PE Ratio | 17.15 |
| Normalized PE Ratio | 19.67 |